Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Smad pathway is a central signaling mechanism that transduces extracellular signals from the TGF-β superfamily of cytokines (including TGF-βs, activins, and BMPs) through membrane serine/threonine kinase receptors to intracellular Smad proteins, which then regulate gene transcription in the nucleus. Regulation of the Smad pathway refers to the finely-tuned modulation of Smad protein activation, nuclear translocation, complex formation, and DNA binding, as well as modulation by inhibitory factors (e.g., Smad7). Smad pathway regulation ensures context-dependent outcomes such as growth arrest, differentiation, immune modulation, and tissue remodeling, and its dysregulation is implicated in cancer, fibrosis, inflammatory and autoimmune diseases. Note: If your intention is to find a single molecule, such as a Smad protein (e.g., Smad2, Smad3, Smad4, Smad7) or a receptor (e.g., TGF-β receptor I/II), you should specify that molecule or gene, as "Smad pathway regulation" is not itself a single canonical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulation of Smad signaling pathway.